These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 395502)

  • 1. [Effects of minoxidil on blood pressure and plasma volume in refractory hypertension (author's transl)].
    Plouin PF; Morgado Vital A; Alhenc-Gelas F; Ménard J
    Nouv Presse Med; 1979 Oct; 8(39):3135-8. PubMed ID: 395502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minoxidil in refractory hypertension. Effects on blood pressure, plasma volume and muscle blood flow.
    Andersson O; Sivertsson R
    Acta Med Scand; 1979; 205(3):213-9. PubMed ID: 34316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long term minoxidil therapy in resistant hypertension: effects on blood pressure, on end-organ damage, and side-effects (author's transl)].
    Plouin PF; Fermé I; Vital-Morgado A; Ménard J
    Therapie; 1980; 35(5):641-3. PubMed ID: 7209862
    [No Abstract]   [Full Text] [Related]  

  • 5. [A cross-over comparison of dihydralazine and minoxidil in severe hypertension (author's transl)].
    Rumboldt Z; Jurisić M; Bagatin J
    Lijec Vjesn; 1982 Feb; 104(2):64-8. PubMed ID: 7050574
    [No Abstract]   [Full Text] [Related]  

  • 6. Minoxidil in the management of intractable hypertension.
    Mackay A; Isles C; Henderson I; Fife R; Kennedy AC
    Q J Med; 1981; 50(198):175-90. PubMed ID: 7302117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minoxidil in treatment resistant hypertension].
    Tenschert W; Vetter W; Studer A; Reuteler H; Furrer J; Nussberger J; Siegenthaler W
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1869-73. PubMed ID: 531565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of renal function during long-term treatment of severe hypertension with minoxidil.
    Taverner D; Bing RF; Heagerty A; Russell GI; Pohl JE; Swales JD; Thurston H
    Q J Med; 1983; 52(206):280-7. PubMed ID: 6611842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
    O'Malley K; Velasco M; Wells J; McNay JL
    J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)].
    Kindler J; Glöckner WM; Sieberth HG; Konrads A; Meurer KA; Schulz V; Vaith P
    Dtsch Med Wochenschr; 1981 Sep; 106(37):1176-81. PubMed ID: 7343274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid control of severe hypertension with minoxidil.
    Alpert MA; Bauer JH
    Arch Intern Med; 1982 Nov; 142(12):2099-104. PubMed ID: 6753777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
    Lammintausta R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):581-4. PubMed ID: 365799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term minoxidil therapy in patients with refractory hypertension and renal disease.
    Bennett WM; Hartnett M; Kuehnel E; McDonald WJ; Porter GA
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():80-4. PubMed ID: 1029893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension.
    Werning C
    Klin Wochenschr; 1976 Aug; 54(15):727-34. PubMed ID: 790007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term minoxidil treatment in refractory hypertension and renal failure.
    Pontremoli R; Robaudo C; Gaiter A; Massarino F; Deferrari G
    Clin Nephrol; 1991 Jan; 35(1):39-43. PubMed ID: 2007295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure.
    Mutterperl RE; Diamond FB; Lowenthal DT
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):498-509. PubMed ID: 789412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minoxidil in the treatment of malignant hypertension (author's transl)].
    Höffler D; Demers HG
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1766-8. PubMed ID: 21786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy.
    Meier A; Weidmann P; Ziegler WH
    Klin Wochenschr; 1981 Nov; 59(22):1231-6. PubMed ID: 6796750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of minoxidil on blood pressure and hemodynamics in severe hypertension.
    Bryan RK; Hoobler SW; Rosenzweig J; Weller JM; Purdy JM
    Am J Cardiol; 1977 May; 39(6):796-801. PubMed ID: 324257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.